This is just a small portion of what this drug can do. When successful, this will be used for all types of ortho needs. IMO this stock should be much higher and most likely will once data is released. The Lead Dr. should be nominated for Nobel Prize if successful. I am excited!!
In adults 60 years old and older the prevalence of radiographic and symptomatic knee OA is 37% and 12% respectively
Only effective treatment for knee OA is joint replacement – a $6.2 billion market in the US by 2017
Ortho needs? C'mon! You're right, but only seeing a few trees and missing the forest. Ortho is a just a small fraction of Ampion applications. Think "inflammation" and all that entails. Ampion can have wider application than aspirin - but with stellar effectiveness.. ... and yes.... I too, think Nobel Prize might be in order once all is known.